ITGAM and neoplasm: GEM is a deoxycytidine analog that inhibits ribonucleotide reductase and selectively depletes CD11b+Gr1+ myeloid cells in tumor-bearing animals where these cells are immunosuppressive, and thereby enhances anti-tumor immune responses (36).